0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Beta Secretase 1 Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-24G9216
Home | Market Reports | Health| Pharmacy
Global Beta Secretase 1 Market Insights and Forecast to 2028
BUY CHAPTERS

Global Beta Secretase 1 Market Research Report 2025

Code: QYRE-Auto-24G9216
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Beta Secretase 1 Market

The global market for Beta Secretase 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Beta Secretase 1 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Beta Secretase 1 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Beta Secretase 1 include Allgenesis Biotherapeutics Inc, Amgen Inc, AstraZeneca Plc, Bristol-Myers Squibb Co, Eisai Co Ltd, Eli Lilly and Co, Genentech Inc, H. Lundbeck A/S, Johnson & Johnson, Merck & Co Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Beta Secretase 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta Secretase 1.
The Beta Secretase 1 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Beta Secretase 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta Secretase 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Beta Secretase 1 Market Report

Report Metric Details
Report Name Beta Secretase 1 Market
Segment by Type
  • AVCRI-175P1
  • CNP-520
  • Elenbecestat
  • ER-901356
  • GNE-892
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allgenesis Biotherapeutics Inc, Amgen Inc, AstraZeneca Plc, Bristol-Myers Squibb Co, Eisai Co Ltd, Eli Lilly and Co, Genentech Inc, H. Lundbeck A/S, Johnson & Johnson, Merck & Co Inc, Novartis AG, Pfizer Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Beta Secretase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Beta Secretase 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Beta Secretase 1 Market report?

Ans: The main players in the Beta Secretase 1 Market are Allgenesis Biotherapeutics Inc, Amgen Inc, AstraZeneca Plc, Bristol-Myers Squibb Co, Eisai Co Ltd, Eli Lilly and Co, Genentech Inc, H. Lundbeck A/S, Johnson & Johnson, Merck & Co Inc, Novartis AG, Pfizer Inc

What are the Application segmentation covered in the Beta Secretase 1 Market report?

Ans: The Applications covered in the Beta Secretase 1 Market report are Alzheimer's Disease, Dementia Associated With Alzheimer's Disease, Mild Cognitive Impairment, Others

What are the Type segmentation covered in the Beta Secretase 1 Market report?

Ans: The Types covered in the Beta Secretase 1 Market report are AVCRI-175P1, CNP-520, Elenbecestat, ER-901356, GNE-892, Others

Recommended Reports

Neuroscience Drugs

Biopharmaceutical Manufacturing

Genomics & Therapeutics

1 Beta Secretase 1 Market Overview
1.1 Product Definition
1.2 Beta Secretase 1 by Type
1.2.1 Global Beta Secretase 1 Market Value Comparison by Type (2024 VS 2031)
1.2.2 AVCRI-175P1
1.2.3 CNP-520
1.2.4 Elenbecestat
1.2.5 ER-901356
1.2.6 GNE-892
1.2.7 Others
1.3 Beta Secretase 1 by Application
1.3.1 Global Beta Secretase 1 Market Value by Application (2024 VS 2031)
1.3.2 Alzheimer's Disease
1.3.3 Dementia Associated With Alzheimer's Disease
1.3.4 Mild Cognitive Impairment
1.3.5 Others
1.4 Global Beta Secretase 1 Market Size Estimates and Forecasts
1.4.1 Global Beta Secretase 1 Revenue 2020-2031
1.4.2 Global Beta Secretase 1 Sales 2020-2031
1.4.3 Global Beta Secretase 1 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Beta Secretase 1 Market Competition by Manufacturers
2.1 Global Beta Secretase 1 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Beta Secretase 1 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Beta Secretase 1 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Beta Secretase 1, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Beta Secretase 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Beta Secretase 1, Product Type & Application
2.7 Global Key Manufacturers of Beta Secretase 1, Date of Enter into This Industry
2.8 Global Beta Secretase 1 Market Competitive Situation and Trends
2.8.1 Global Beta Secretase 1 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Beta Secretase 1 Players Market Share by Revenue
2.8.3 Global Beta Secretase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Beta Secretase 1 Market Scenario by Region
3.1 Global Beta Secretase 1 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Beta Secretase 1 Sales by Region: 2020-2031
3.2.1 Global Beta Secretase 1 Sales by Region: 2020-2025
3.2.2 Global Beta Secretase 1 Sales by Region: 2026-2031
3.3 Global Beta Secretase 1 Revenue by Region: 2020-2031
3.3.1 Global Beta Secretase 1 Revenue by Region: 2020-2025
3.3.2 Global Beta Secretase 1 Revenue by Region: 2026-2031
3.4 North America Beta Secretase 1 Market Facts & Figures by Country
3.4.1 North America Beta Secretase 1 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Beta Secretase 1 Sales by Country (2020-2031)
3.4.3 North America Beta Secretase 1 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Beta Secretase 1 Market Facts & Figures by Country
3.5.1 Europe Beta Secretase 1 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Beta Secretase 1 Sales by Country (2020-2031)
3.5.3 Europe Beta Secretase 1 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Beta Secretase 1 Market Facts & Figures by Region
3.6.1 Asia Pacific Beta Secretase 1 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Beta Secretase 1 Sales by Region (2020-2031)
3.6.3 Asia Pacific Beta Secretase 1 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Beta Secretase 1 Market Facts & Figures by Country
3.7.1 Latin America Beta Secretase 1 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Beta Secretase 1 Sales by Country (2020-2031)
3.7.3 Latin America Beta Secretase 1 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Beta Secretase 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Beta Secretase 1 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Beta Secretase 1 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Beta Secretase 1 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Beta Secretase 1 Sales by Type (2020-2031)
4.1.1 Global Beta Secretase 1 Sales by Type (2020-2025)
4.1.2 Global Beta Secretase 1 Sales by Type (2026-2031)
4.1.3 Global Beta Secretase 1 Sales Market Share by Type (2020-2031)
4.2 Global Beta Secretase 1 Revenue by Type (2020-2031)
4.2.1 Global Beta Secretase 1 Revenue by Type (2020-2025)
4.2.2 Global Beta Secretase 1 Revenue by Type (2026-2031)
4.2.3 Global Beta Secretase 1 Revenue Market Share by Type (2020-2031)
4.3 Global Beta Secretase 1 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Beta Secretase 1 Sales by Application (2020-2031)
5.1.1 Global Beta Secretase 1 Sales by Application (2020-2025)
5.1.2 Global Beta Secretase 1 Sales by Application (2026-2031)
5.1.3 Global Beta Secretase 1 Sales Market Share by Application (2020-2031)
5.2 Global Beta Secretase 1 Revenue by Application (2020-2031)
5.2.1 Global Beta Secretase 1 Revenue by Application (2020-2025)
5.2.2 Global Beta Secretase 1 Revenue by Application (2026-2031)
5.2.3 Global Beta Secretase 1 Revenue Market Share by Application (2020-2031)
5.3 Global Beta Secretase 1 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allgenesis Biotherapeutics Inc
6.1.1 Allgenesis Biotherapeutics Inc Company Information
6.1.2 Allgenesis Biotherapeutics Inc Description and Business Overview
6.1.3 Allgenesis Biotherapeutics Inc Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allgenesis Biotherapeutics Inc Beta Secretase 1 Product Portfolio
6.1.5 Allgenesis Biotherapeutics Inc Recent Developments/Updates
6.2 Amgen Inc
6.2.1 Amgen Inc Company Information
6.2.2 Amgen Inc Description and Business Overview
6.2.3 Amgen Inc Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Inc Beta Secretase 1 Product Portfolio
6.2.5 Amgen Inc Recent Developments/Updates
6.3 AstraZeneca Plc
6.3.1 AstraZeneca Plc Company Information
6.3.2 AstraZeneca Plc Description and Business Overview
6.3.3 AstraZeneca Plc Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Plc Beta Secretase 1 Product Portfolio
6.3.5 AstraZeneca Plc Recent Developments/Updates
6.4 Bristol-Myers Squibb Co
6.4.1 Bristol-Myers Squibb Co Company Information
6.4.2 Bristol-Myers Squibb Co Description and Business Overview
6.4.3 Bristol-Myers Squibb Co Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bristol-Myers Squibb Co Beta Secretase 1 Product Portfolio
6.4.5 Bristol-Myers Squibb Co Recent Developments/Updates
6.5 Eisai Co Ltd
6.5.1 Eisai Co Ltd Company Information
6.5.2 Eisai Co Ltd Description and Business Overview
6.5.3 Eisai Co Ltd Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eisai Co Ltd Beta Secretase 1 Product Portfolio
6.5.5 Eisai Co Ltd Recent Developments/Updates
6.6 Eli Lilly and Co
6.6.1 Eli Lilly and Co Company Information
6.6.2 Eli Lilly and Co Description and Business Overview
6.6.3 Eli Lilly and Co Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly and Co Beta Secretase 1 Product Portfolio
6.6.5 Eli Lilly and Co Recent Developments/Updates
6.7 Genentech Inc
6.7.1 Genentech Inc Company Information
6.7.2 Genentech Inc Description and Business Overview
6.7.3 Genentech Inc Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Genentech Inc Beta Secretase 1 Product Portfolio
6.7.5 Genentech Inc Recent Developments/Updates
6.8 H. Lundbeck A/S
6.8.1 H. Lundbeck A/S Company Information
6.8.2 H. Lundbeck A/S Description and Business Overview
6.8.3 H. Lundbeck A/S Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.8.4 H. Lundbeck A/S Beta Secretase 1 Product Portfolio
6.8.5 H. Lundbeck A/S Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Company Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson & Johnson Beta Secretase 1 Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Merck & Co Inc
6.10.1 Merck & Co Inc Company Information
6.10.2 Merck & Co Inc Description and Business Overview
6.10.3 Merck & Co Inc Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Merck & Co Inc Beta Secretase 1 Product Portfolio
6.10.5 Merck & Co Inc Recent Developments/Updates
6.11 Novartis AG
6.11.1 Novartis AG Company Information
6.11.2 Novartis AG Description and Business Overview
6.11.3 Novartis AG Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novartis AG Beta Secretase 1 Product Portfolio
6.11.5 Novartis AG Recent Developments/Updates
6.12 Pfizer Inc
6.12.1 Pfizer Inc Company Information
6.12.2 Pfizer Inc Description and Business Overview
6.12.3 Pfizer Inc Beta Secretase 1 Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pfizer Inc Beta Secretase 1 Product Portfolio
6.12.5 Pfizer Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Beta Secretase 1 Industry Chain Analysis
7.2 Beta Secretase 1 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Beta Secretase 1 Production Mode & Process Analysis
7.4 Beta Secretase 1 Sales and Marketing
7.4.1 Beta Secretase 1 Sales Channels
7.4.2 Beta Secretase 1 Distributors
7.5 Beta Secretase 1 Customer Analysis
8 Beta Secretase 1 Market Dynamics
8.1 Beta Secretase 1 Industry Trends
8.2 Beta Secretase 1 Market Drivers
8.3 Beta Secretase 1 Market Challenges
8.4 Beta Secretase 1 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Beta Secretase 1 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Beta Secretase 1 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Beta Secretase 1 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Beta Secretase 1 Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Beta Secretase 1 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Beta Secretase 1 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Beta Secretase 1 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Beta Secretase 1 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Beta Secretase 1, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Beta Secretase 1, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Beta Secretase 1, Product Type & Application
 Table 12. Global Key Manufacturers of Beta Secretase 1, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Beta Secretase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta Secretase 1 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Beta Secretase 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Beta Secretase 1 Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Beta Secretase 1 Sales Market Share by Region (2020-2025)
 Table 19. Global Beta Secretase 1 Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Beta Secretase 1 Sales Market Share by Region (2026-2031)
 Table 21. Global Beta Secretase 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Beta Secretase 1 Revenue Market Share by Region (2020-2025)
 Table 23. Global Beta Secretase 1 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Beta Secretase 1 Revenue Market Share by Region (2026-2031)
 Table 25. North America Beta Secretase 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Beta Secretase 1 Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Beta Secretase 1 Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Beta Secretase 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Beta Secretase 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Beta Secretase 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Beta Secretase 1 Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Beta Secretase 1 Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Beta Secretase 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Beta Secretase 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Beta Secretase 1 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Beta Secretase 1 Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Beta Secretase 1 Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Beta Secretase 1 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Beta Secretase 1 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Beta Secretase 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Beta Secretase 1 Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Beta Secretase 1 Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Beta Secretase 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Beta Secretase 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Beta Secretase 1 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Beta Secretase 1 Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Beta Secretase 1 Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Beta Secretase 1 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Beta Secretase 1 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Beta Secretase 1 Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Beta Secretase 1 Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Beta Secretase 1 Sales Market Share by Type (2020-2025)
 Table 53. Global Beta Secretase 1 Sales Market Share by Type (2026-2031)
 Table 54. Global Beta Secretase 1 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Beta Secretase 1 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Beta Secretase 1 Revenue Market Share by Type (2020-2025)
 Table 57. Global Beta Secretase 1 Revenue Market Share by Type (2026-2031)
 Table 58. Global Beta Secretase 1 Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Beta Secretase 1 Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Beta Secretase 1 Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Beta Secretase 1 Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Beta Secretase 1 Sales Market Share by Application (2020-2025)
 Table 63. Global Beta Secretase 1 Sales Market Share by Application (2026-2031)
 Table 64. Global Beta Secretase 1 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Beta Secretase 1 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Beta Secretase 1 Revenue Market Share by Application (2020-2025)
 Table 67. Global Beta Secretase 1 Revenue Market Share by Application (2026-2031)
 Table 68. Global Beta Secretase 1 Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Beta Secretase 1 Price (USD/Pcs) by Application (2026-2031)
 Table 70. Allgenesis Biotherapeutics Inc Company Information
 Table 71. Allgenesis Biotherapeutics Inc Description and Business Overview
 Table 72. Allgenesis Biotherapeutics Inc Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Allgenesis Biotherapeutics Inc Beta Secretase 1 Product
 Table 74. Allgenesis Biotherapeutics Inc Recent Developments/Updates
 Table 75. Amgen Inc Company Information
 Table 76. Amgen Inc Description and Business Overview
 Table 77. Amgen Inc Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Amgen Inc Beta Secretase 1 Product
 Table 79. Amgen Inc Recent Developments/Updates
 Table 80. AstraZeneca Plc Company Information
 Table 81. AstraZeneca Plc Description and Business Overview
 Table 82. AstraZeneca Plc Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Plc Beta Secretase 1 Product
 Table 84. AstraZeneca Plc Recent Developments/Updates
 Table 85. Bristol-Myers Squibb Co Company Information
 Table 86. Bristol-Myers Squibb Co Description and Business Overview
 Table 87. Bristol-Myers Squibb Co Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Bristol-Myers Squibb Co Beta Secretase 1 Product
 Table 89. Bristol-Myers Squibb Co Recent Developments/Updates
 Table 90. Eisai Co Ltd Company Information
 Table 91. Eisai Co Ltd Description and Business Overview
 Table 92. Eisai Co Ltd Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Eisai Co Ltd Beta Secretase 1 Product
 Table 94. Eisai Co Ltd Recent Developments/Updates
 Table 95. Eli Lilly and Co Company Information
 Table 96. Eli Lilly and Co Description and Business Overview
 Table 97. Eli Lilly and Co Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Eli Lilly and Co Beta Secretase 1 Product
 Table 99. Eli Lilly and Co Recent Developments/Updates
 Table 100. Genentech Inc Company Information
 Table 101. Genentech Inc Description and Business Overview
 Table 102. Genentech Inc Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Genentech Inc Beta Secretase 1 Product
 Table 104. Genentech Inc Recent Developments/Updates
 Table 105. H. Lundbeck A/S Company Information
 Table 106. H. Lundbeck A/S Description and Business Overview
 Table 107. H. Lundbeck A/S Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. H. Lundbeck A/S Beta Secretase 1 Product
 Table 109. H. Lundbeck A/S Recent Developments/Updates
 Table 110. Johnson & Johnson Company Information
 Table 111. Johnson & Johnson Description and Business Overview
 Table 112. Johnson & Johnson Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Johnson & Johnson Beta Secretase 1 Product
 Table 114. Johnson & Johnson Recent Developments/Updates
 Table 115. Merck & Co Inc Company Information
 Table 116. Merck & Co Inc Description and Business Overview
 Table 117. Merck & Co Inc Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Merck & Co Inc Beta Secretase 1 Product
 Table 119. Merck & Co Inc Recent Developments/Updates
 Table 120. Novartis AG Company Information
 Table 121. Novartis AG Description and Business Overview
 Table 122. Novartis AG Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Novartis AG Beta Secretase 1 Product
 Table 124. Novartis AG Recent Developments/Updates
 Table 125. Pfizer Inc Company Information
 Table 126. Pfizer Inc Description and Business Overview
 Table 127. Pfizer Inc Beta Secretase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Pfizer Inc Beta Secretase 1 Product
 Table 129. Pfizer Inc Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Beta Secretase 1 Distributors List
 Table 133. Beta Secretase 1 Customers List
 Table 134. Beta Secretase 1 Market Trends
 Table 135. Beta Secretase 1 Market Drivers
 Table 136. Beta Secretase 1 Market Challenges
 Table 137. Beta Secretase 1 Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Beta Secretase 1
 Figure 2. Global Beta Secretase 1 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Beta Secretase 1 Market Share by Type: 2024 & 2031
 Figure 4. AVCRI-175P1 Product Picture
 Figure 5. CNP-520 Product Picture
 Figure 6. Elenbecestat Product Picture
 Figure 7. ER-901356 Product Picture
 Figure 8. GNE-892 Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Beta Secretase 1 Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Beta Secretase 1 Market Share by Application: 2024 & 2031
 Figure 12. Alzheimer's Disease
 Figure 13. Dementia Associated With Alzheimer's Disease
 Figure 14. Mild Cognitive Impairment
 Figure 15. Others
 Figure 16. Global Beta Secretase 1 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Beta Secretase 1 Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Beta Secretase 1 Sales (2020-2031) & (K Pcs)
 Figure 19. Global Beta Secretase 1 Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Beta Secretase 1 Report Years Considered
 Figure 21. Beta Secretase 1 Sales Share by Manufacturers in 2024
 Figure 22. Global Beta Secretase 1 Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Beta Secretase 1 Players: Market Share by Revenue in Beta Secretase 1 in 2024
 Figure 24. Beta Secretase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Beta Secretase 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Beta Secretase 1 Sales Market Share by Country (2020-2031)
 Figure 27. North America Beta Secretase 1 Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Beta Secretase 1 Sales Market Share by Country (2020-2031)
 Figure 31. Europe Beta Secretase 1 Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Beta Secretase 1 Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Beta Secretase 1 Revenue Market Share by Region (2020-2031)
 Figure 39. China Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Beta Secretase 1 Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Beta Secretase 1 Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Beta Secretase 1 Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Beta Secretase 1 Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Beta Secretase 1 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Beta Secretase 1 by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Beta Secretase 1 by Type (2020-2031)
 Figure 61. Global Beta Secretase 1 Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Beta Secretase 1 by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Beta Secretase 1 by Application (2020-2031)
 Figure 64. Global Beta Secretase 1 Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Beta Secretase 1 Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart